About AgelessRx

AgelessRx is a first-of-its-kind, longevity-focused telehealth platform with an e-commerce component. Our mission is to collectively give people millions of extra healthy years, so everyone can enjoy more of what they love in a world where people are empowered to live as long as they want. We believe aging should no longer be treated as a dreadful inevitability, but instead, as a puzzle that can be solved, a fight that can be fought – just as a disease with a cure. Through our free-to-use platform, we offer trusted, data-driven longevity solutions and scientifically backed prescription therapies to help safely lower the risk of age-related diseases.

About the role

AgelessRx is seeking a hands-on, highly analytical Vice President of Growth & Marketing to lead and operationalize our marketing organization. This is not a traditional brand-marketing or executive-oversight role. We are looking for a performance-oriented operator who has personally been deep in growth channels, experimentation, funnels, CAC/LTV economics, and scaling DTC businesses - and who now knows how to build systems and teams that consistently produce results.

This person will own the marketing operating layer across paid acquisition, lifecycle marketing, retention, analytics, experimentation, and brand. They will be responsible for aligning priorities across functions, improving organizational execution, managing performance, and ensuring the marketing organization operates as a cohesive system rather than a collection of disconnected channels.

The ideal candidate combines strategic thinking with strong execution instincts. They know how to build teams, create accountability, identify blind spots, prioritize aggressively, and push growth forward through disciplined experimentation and operational excellence.

What you'll do

Team Leadership & Cross-Functional Alignment

Hire, develop, coach, performance-manage, and hold accountable marketing team members, channel owners, agencies, vendors, and external partners.
Brings their own ideas, tactics, and growth initiatives to the table - and has the credibility and track record to push the team to implement them. This is not a role that simply manages what others propose.
Ensure AgelessRx’s value proposition is consistently reflected across campaigns, landing pages, content, lifecycle communications, and customer touchpoints.
Partner with brand, content, digital marketing, product, clinical, legal, compliance, finance, and executive teams to align marketing execution with business goals, customer experience, and healthcare standards.
Serve as the senior marketing leader responsible for connecting team-level execution to company-level priorities.
Ensure the marketing organization has the right people, systems, and decision-making structures to scale effectively.

Marketing Strategy & Growth Priorities

Own the marketing function across paid media, lifecycle marketing, brand, growth analytics, experimentation, and acquisition/retention channels.
Set growth priorities, budget guardrails, CAC/LTV expectations, channel-level targets, and ROI standards.
Determine which channels, audiences, campaigns, and initiatives should be scaled, tested, optimized, or deprioritized.
Partner with Finance to maintain the growth financial model, including spend levels, marginal ROI, CAC, LTV, payback, and channel-level scaling decisions.
Translate channel performance, experiment results, growth priorities, and marketing investment decisions into clear business implications for the executive team.

Execution, Operating Rhythm & Accountability

Lead the marketing team day to day, ensuring paid media, lifecycle, brand, analytics, and experimentation work together as an integrated system.
Own the team’s operating rhythm, including performance reviews, prioritization meetings, decision forums, reporting cadence, follow-through, and accountability mechanisms.
Improve execution quality by spotting blind spots, resolving dependencies, removing blockers, and keeping the team focused on the highest-impact work.
Redirect, sharpen, escalate, or change the approach when experiments, campaigns, channels, or team workflows are not producing results.
Build a proactive, high-accountability culture that enables high-agency team members without adding unnecessary process or bureaucracy.
Owns go-to-market for new product launches - funnel architecture, positioning, offer structure, and the experiment roadmap for each new product line entering the market."

Experimentation, Analytics & Performance Management

Hold accountability for the experimentation roadmap’s business impact, even if the Growth PMM owns day-to-day test coordination.
Ensure every major experiment has a clear hypothesis, owner, timeline, success metric, sample size, and decision rule.
Establish and manage reporting frameworks across CAC, LTV, payback, conversion, retention, channel efficiency, and ROI.
Periodically audit paid media and growth channels at a structural level, ensuring account architecture, bidding strategy, measurement, reporting, and optimization practices are sound.
Reallocate budget, people, and attention based on performance data, cutting low-return efforts and investing in KPI-backed growth opportunities.

What success looks like

At 45 Days: The marketing team has a clear operating rhythm, channel owners and agencies are being held to weekly commitments, and performance reporting is trusted and actionable without CEO involvement.
At 90 Days: Growth metrics are improving across CAC, LTV, and funnel conversion. The experimentation engine is compounding. The team is performing above where it was before this person arrived — individually and collectively.

Qualifications

10+ years of experience in growth, performance, or digital marketing, with significant experience leading high-performing marketing organizations in fast-paced, high-growth environments.
Proven track record of scaling customer acquisition and retention programs while maintaining efficient CAC/LTV economics.
Deep enough fluency across paid channels (Google, Meta, affiliates) to challenge channel owners credibly, and know when performance explanations don't add up — without personally running campaigns day-to-day.
Demonstrated experience building and managing high-velocity experimentation programs focused on measurable business impact.
Strong analytical and quantitative skillset with the ability to interpret complex performance data and translate insights into actionable strategies.
Experience building and managing marketing financial models, forecasting growth performance, and making data-driven budget allocation decisions.
Strong understanding of attribution, analytics, funnel optimization, and marketing measurement frameworks.
Experience leading and developing cross-functional teams, including hiring, coaching, performance management, and organizational design.

[{'location': 'Remote (United States)', 'currency': 'USD', 'frequency': 'YEAR', 'rangeStart': 275000.0, 'rangeEnd': 325000.0, 'isRemote': True}]

About the company

AgelessRx offers telehealth-based longevity care, providing access to prescription medications and therapies aimed at slowing aging and preventing age-related diseases. Its products include Metformin, Low Dose Naltrexone (LDN), NAD+ patches, and Galleri cancer screening, all available through a direct-to-consumer subscription model. Customers complete online consultations with healthcare professionals, receive prescriptions, and have treatments delivered to their homes. The company differentiates itself with science-backed treatment options, educational resources, and a portion of profits directed toward longevity research and advocacy, positioning itself to serve consumers seeking proactive health management. Its goal is to help people extend their healthspan by making preventative anti-aging care more accessible and by supporting scientific progress in longevity.

Company Size

51-200

Company Stage

Grant

Total Funding

$1M

Headquarters

Ann Arbor, Michigan

Founded

2019

Get referred to AgelessRx

See people who can refer or advise you

Simplify's Take

What believers are saying

AgelessRx won a $1 million XPRIZE Milestone 2 award in August 2026.
The finals protocol includes compounded tirzepatide, rapamycin, and metformin, expanding treatment breadth.
Public filings show $5.5 million raised in 2026, supporting near-term execution.

What critics are saying

AgelessRx disclosed a 2026 breach exposing diagnoses, medications, and addresses to attackers.
Its 2026 pilot had only 18 analyzed participants, too small for durable efficacy claims.
The finals trial runs through 2029, leaving commercialization and validation unresolved for years.

What makes AgelessRx unique

AgelessRx reached XPRIZE Healthspan finals in 2026 from 600-plus global teams.
Its 2026 trial bundles nine agents with resistance training and virtual coaching.
The company combines telehealth delivery with clinical research, not just supplement commerce.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Flexible Work Hours
Remote Work Options

Growth & Insights and Company News

Headcount

6 month growth

1 year growth

2 year growth

Business Wire

Aug 12th, 2026

AgelessRx named one of America's fastest-growing private companies by Inc. for second consecutive year.

AgelessRx named one of America's fastest-growing private companies by Inc. for second consecutive year. The mission-driven longevity care leader earns a place on the 2026 Inc. 5000 following continued growth, scientific progress, and expanding access to proactive care. ANN ARBOR, Mich.-(BUSINESS WIRE)-AgelessRx, the first-of-its-kind longevity care platform making proactive, evidence-informed care more accessible, has been named to the 2026 Inc. 5000 list of the fastest-growing private companies in America for the second year in a row. The Inc. 5000 recognizes privately held companies based on three-year revenue growth and is widely regarded as a benchmark of private business success in the United States. Past honorees include Microsoft, Zappos, Intuit, Patagonia, and Under Armour. "Making the Inc. 5000 for a second consecutive year represents more than our growth," said Anar Isman, CEO and Co-Founder of AgelessRx. "It reflects growing demand for personalized longevity care and our ability to meet that demand." AgelessRx is building a new model for longevity care that brings together clinician-guided treatment, ongoing support, and longevity research in one accessible online platform. Its fully in-house clinical and research teams help translate emerging longevity science into practical care, while ongoing clinical trials and real-world health data contribute to a growing body of evidence around healthier aging. The company's continued growth has also been matched by meaningful scientific progress. In August 2026, AgelessRx was selected as a finalist and Milestone 2 Awardee in the XPRIZE Healthspan competition, further validating its work to advance accessible, clinically tested approaches to healthier aging. As interest in proactive, personalized longevity care continues to grow, AgelessRx is focused on making evidence-informed strategies for healthier aging a practical part of everyday healthcare. To learn more about AgelessRx, visit www.agelessrx.com. For the full Inc. 5000 list, please visit www.inc.com/inc5000. About AgelessRx AgelessRx is helping redefine how people age, combining clinically validated treatments with cutting-edge longevity science to support longer, healthier lives. The company advances the field through ongoing research and clinical trials while making proactive, evidence-informed care more accessible through its online platform. Follow AgelessRx on Instagram, TikTok, X, and Facebook. About Inc. Inc. is the leading media brand and playbook for entrepreneurs and business. Through its journalism, Inc. aims to inform, educate, and elevate the profile of its community: the risk-takers, the innovators, and the ultra-driven go-getters who are creating the future of business. Inc. is published by Mansueto Ventures LLC, along with fellow leading business publication Fast Company. For more information, visit www.inc.com. More News From AgelessRx ANN ARBOR, Mich.-( BUSINESS WIRE )-AgelessRx, a longevity-focused telehealth platform advancing evidence-based interventions and real-world clinical research, today announced that it has been selected as one of 10 Milestone 2 awardees in the $101 million XPRIZE Healthspan competition, selected to receive a $1 million Milestone 2 Award. AgelessRx and its Stanford PhD-led Research Team were chosen from over 600 global pre-registered teams working to transform how people age. XPRIZE Healthspan is... AgelessRx. Release Versions

AgelessRx

Aug 11th, 2026

AgelessRx named XPRIZE Healthspan Milestone 2 awardee and awarded $1 million to advance healthy aging clinical trial.

AgelessRx named XPRIZE Healthspan Milestone 2 awardee and awarded $1 million to advance healthy aging clinical trial. AgelessRx, a longevity-focused telehealth platform advancing evidence-based interventions and real-world clinical research, today announced that it has been selected as one of 10 Milestone 2 awardees in the $101 million XPRIZE Healthspan competition, selected to receive a $1 million Milestone 2 Award. AgelessRx and its Stanford PhD-led Research Team were chosen from over 600 global pre-registered teams. These teams are working to transform how people age. XPRIZE Healthspan is a 7-year global competition incentivizing teams to develop and test therapeutics. These therapeutics aim to restore muscle, cognition, and immune function. The goal is to extend healthy life in adults aged 50-90 by a minimum of 10 years. The competition has an ambitious goal of extending healthy life by 20 years within one year or less of treatment. "Aging does not happen through one pathway, so the future of longevity cannot rely on one intervention," said Stefanie Morgan, PhD, Vice President of Research and Applied Science at AgelessRx. "Becoming an XPRIZE Healthspan finalist brings us closer to the future AgelessRx was built to create, where rigorous longevity research does not stay in the lab, but becomes evidence-led care people can actually access." Inside AgelessRx's 90-day pilot study. AgelessRx earned its place in the final phase after completing a 90-day randomized, placebo-controlled pilot study. The study evaluated combinations of known gerotherapeutics alongside structured lifestyle support. The study enrolled 26 adults aged 60-80 at risk for age-related functional decline. The final analysis included 18 participants. Participants joined a placebo group or one of two active intervention groups. The groups evaluated combinations of Low Dose Naltrexone, Metformin, NAD+, Vitamin B12, Low Dose Rapamycin, Glutathione, and AgelessRx's Infinite supplement. Participants also followed exercise and guided meditation programs. "For most of history, we've accepted aging as something that just happens to us," said Anar Isman, CEO and Co-Founder of AgelessRx. "Becoming an XPRIZE Healthspan finalist is a chance to prove that aging is something we can measure, target, and reverse - and put that power in the hands of everyday people, not just the lucky few." What comes next in the XPRIZE final stage. For the final phase, AgelessRx plans to conduct a fully powered, one-year randomized controlled trial. The trial will involve approximately 186 adults aged 50-90. Participants will join either an intervention or placebo group. A coordinated research infrastructure will support the final trials between 2026 and 2029. The University of Utah Data Coordinating Center will oversee trial and data management. The University of California San Diego Stein Institute for Research on Aging will coordinate shared laboratories, biomarkers, and biological-sample storage. XPRIZE expects to award a grand prize of up to $81 million in 2030. The global longevity economy is projected to reach $8 trillion by 2030, driving increased demand for solutions that allow people to live healthier, longer. Age-related diseases account for over 55% of global healthcare spending. This highlights the need for scalable, evidence-based interventions that target the root causes of aging. AgelessRx's selection underscores the potential to bring high-impact, clinically guided longevity care at scale. It also reflects the opportunity within a rapidly growing global market. Advancing accessible, science-backed longevity care. By combining clinical precision, digital access, and a mission to democratize science-backed longevity care, AgelessRx is proud to stand at the forefront of the healthspan revolution. As demand grows for established, preventive solutions, this XPRIZE milestone reinforces AgelessRx's role in delivering therapies that allow users to proactively take control of their health journeys.

Associated Press

Aug 11th, 2026

AgelessRx wins $1M XPRIZE Healthspan award to advance healthy ageing clinical trial

AgelessRx, a longevity-focused telehealth platform, has been named one of 10 Milestone 2 awardees in the $101 million XPRIZE Healthspan competition, receiving a $1 million award. The company was selected from over 600 global teams competing to develop therapeutics that restore muscle, cognition, and immune function to extend healthy life in adults aged 50–90. AgelessRx earned its place after completing a 90-day randomised, placebo-controlled pilot study evaluating combinations of gerotherapeutics alongside lifestyle support. The study enrolled 26 adults aged 60–80. For the final phase, AgelessRx plans to conduct a one-year randomised controlled trial involving approximately 186 adults. Final trials will run between 2026 and 2029, with XPRIZE expected to award a grand prize of up to $81 million in 2030.

TEISS

Jun 29th, 2026

Major security breach at AgelessRx exposed patients' sensitive information.

Major security breach at AgelessRx exposed patients' sensitive information. Telehealth platform AgelessRx said it suffered a significant data security incident earlier this year that compromised the sensitive personal information of its patients and staff. AgelessRx is a U.S.-based tele-health company headquartered in Ann Arbor, Michigan. Founded in 2019, it provides physician-guided longevity and preventive healthcare services, offering online access to prescription therapies, diagnostic testing, and personalised treatments focused on healthy aging and metabolic wellness. In a data security incident notice filed with the Office of California Attorney General, AgelessRx said that on April 22, it identified unauthorised access within its internal network. The healthcare provider immediately launched an investigation, with assistance from external cyber security experts, to determine the nature and scope of the incident. It also took steps to secure the affected systems and notified relevant law enforcement authorities about the incident. "As a result of that investigation, AgelessRx identified that between April 17, 2026 and April 22, 2026, certain help-desk tickets were accessed by an unauthorised actor. AgelessRx is notifying you of this incident because after reviewing the affected data, on May 27, 2026 we determined that your information was included in the affected help-desk tickets," AgelessRx said. The compromised data included names, dates of birth, health diagnosis and conditions, medications, and other treatment information. The company, however, did not share the number of affected individuals. "The confidentiality, privacy, and security of i nformation in our care are among our highest priorities. We are reviewing existing security policies and have implemented additional cybersecurity measures to further protect against similar incidents moving forward," AgelessRx added. The tele-healthcare has advised all affected individuals to regularly monitor their credit reports, account and benefit statements and report any suspicious activity to law enforcement authorities, including the police and the state attorney general. It has also offered complimentary identity protection and credit monitoring services through Experian to all individuals. In April, an unnamed threat group claimed responsibility for the cyber attack on AgelessRx and listed the company as a victim on its data leak site. According to the group, it obtained a database containing sensitive information, including names, email addresses, dates of birth, physical addresses, phone numbers, medical conditions, medications, allergies, prescription details, pharmacy information, and other confidential data. The threat actors also indicated their willingness to sell the stolen database, suggesting that ransom negotiations with the victim were unsuccessful.

Claim Depot

Jun 25th, 2026

AgelessRx data breach exposes patient health information.

AgelessRx data breach exposes patient health information. June 25, 2026 Affected by the data breach? You may be entitled to compensation. Submit a claim today. AgelessRx, a telehealth platform specializing in longevity and anti-aging treatments, disclosed a data breach that exposed sensitive patient health information. On April 22, 2026, AgelessRx became aware of potential unauthorized access to certain files on its system. The company launched an investigation with the assistance of third-party cybersecurity specialists to determine the nature and scope of the activity. The investigation revealed that between April 17 and April 22, 2026, an unauthorized actor gained access to certain help-desk tickets within the company's system. On May 27, 2026, after a review of the affected data, AgelessRx determined which specific individuals had their information included in the compromised tickets. On April 25, 2026, a threat actor using the name "2019" posted on the open web claiming to be selling data obtained from AgelessRx. The listing described the data as containing patient information, including names, email addresses, dates of birth, sex, physical addresses, phone numbers, medical conditions, current medications, allergies and prescription details. The types of information that AgelessRx confirmed as exposed include names, dates of birth, health diagnoses or conditions, medications and other treatment information. The breach was reported to attorneys general of California and Vermont on June 24, 2026. AgelessRx began sending notification letters to affected individuals on June 23, 2026. The company has not publicly disclosed the total number of people affected across the United States. AgelessRx's response to the breach. AgelessRx is offering affected individuals 12 months of complimentary credit monitoring and identity restoration services through Experian IdentityWorks. The membership includes daily credit report monitoring on the individual's Experian credit file, access to identity restoration specialists and $1 million in identity theft insurance underwritten by American Bankers Insurance Company of Florida. Affected individuals can enroll online using the unique activation code included in their notification letter. The enrollment deadline is Sept. 30, 2026. For questions or assistance with enrollment by phone, affected individuals can call 833-918-7837 (toll-free), Monday through Friday, from 8 a.m. to 8 p.m. Central Time, excluding major U.S. holidays. Individuals may also contact AgelessRx by mail at 2370 E Stadium Blvd. #2049, Ann Arbor, MI 48104. Submit your claim to the law firm handling this investigation. Types of INFORMATION affected Notice letter. Sources. Disclosures Breach summary. Affected Entity Date of Breach April 17, 2026 - April 22, 2026